168 related articles for article (PubMed ID: 34412102)
1. Comparison of clinical pharmacogenetic recommendations across therapeutic areas.
Shugg T; Pasternak AL; Luzum JA
Pharmacogenet Genomics; 2022 Feb; 32(2):51-59. PubMed ID: 34412102
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
Shugg T; Pasternak AL; London B; Luzum JA
NPJ Genom Med; 2020; 5():48. PubMed ID: 33145028
[TBL] [Abstract][Full Text] [Related]
3. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
4. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
5. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
[TBL] [Abstract][Full Text] [Related]
6. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
Wang B; Canestaro WJ; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
[TBL] [Abstract][Full Text] [Related]
7. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Vivot A; Boutron I; Ravaud P; Porcher R
Genet Med; 2015 Sep; 17(9):733-8. PubMed ID: 25521333
[TBL] [Abstract][Full Text] [Related]
8. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
9. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
10. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
11. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations.
Luzum JA; Cheung JC
Pharmacogenomics; 2018 Oct; 19(15):1203-1216. PubMed ID: 30196751
[TBL] [Abstract][Full Text] [Related]
14. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
15. The use of pharmacogenetic testing in psychiatry.
Kumar A; Kearney A
J Am Assoc Nurse Pract; 2021 Nov; 33(11):849-851. PubMed ID: 34747904
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
Bousman CA; Jaksa P; Pantelis C
Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
[TBL] [Abstract][Full Text] [Related]
17. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
Stingl JC; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
Lunenburg CATC; Gasse C
Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
[TBL] [Abstract][Full Text] [Related]
20. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]